Valuation models
price $298.23 · as of Nov 2, 2026
DCF · Perpetuity growth · 5yused579.99 – 1,152.83778.4562% undervaluedDCF · Perpetuity growth · 10y643.68 – 1,246.45852.9365% undervaluedDCF · EBITDA exit · 5y861.01 – 947.31902.9767% undervaluedDCF · EBITDA exit · 10y883.99 – 1,053.37964.5269% undervaluedP/E · peers388.68 – 1,417.04565.4947% undervaluedP/E · own history344.89 – 537.03442.9933% undervaluedPEG—551.5246% undervaluedEV/EBITDA · peers456.14 – 774.58697.1957% undervaluedEV/Revenue · peers206.37 – 529.82364.1418% undervaluedEarnings power value922.49 – 1,560.611,165.0774% undervaluedDividend discount144.66 – 408.09228.0031% overvaluedWall St. consensus target—320.007% belowCost of capital (WACC)—6.26%—
DCF · Perpetuity growth · 5y leads for a mature, steady company — positive operating income and three years of positive free cash flow. How the headline model is chosen.
Model value · DCF · Perpetuity growth · 5y
778.45
Cigna closed at $298.23 — undervalued by 62% vs model.
579.99the model's range1,152.83
DCF · Perpetuity growth · 5y leads for a mature, steady company — positive operating income and three years of positive free cash flow. From a five-year discounted cash flow.
Other models
228.00 – 1,165.07
Wall St. target
320.00 7% below
Below model, 1y
26 of 30 days
How it is valued
Valued asMature & stable
Moderate growth (~19% recent)Thin margins (2.2% net margin)Pays dividendsHighly cyclical earningsStrong FCF yield (10.6%)
Model estimates for research reference only, not investment advice. Every model rests on assumptions that may not match what happens; how each model works is in the manual.